BioSpace News Archive

Landmark Bio announced that it has signed a multi-year strategic manufacturing agreement with Galapagos NV (Euronext & NASDAQ: GLPG), an innovative biotech company with operations in Europe and the U.S.

Opening today, the 2023 Milken Institute Future of Health Summit gathers hundreds of speakers and attendees who are inspired to share ideas and advance work around this year’s theme: “Closing the Gap: Better Health for More People.”

Meilleur Technologies, Inc. today announced a research collaboration agreement with the National Institute of Aging (NIA)-sponsored multicenter study called the Consortium for Clarity in ADRD Research Through Imaging (CLARiTI).

Eyenovia, Inc. announced that the Company will release financial results for the third quarter ended September 30, 2023 on Monday, November 13, 2023, after the markets close.

Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that it will host a conference call and live audio webcast on Monday, November 13, 2023 at 4:30 p.m. ET to report its third quarter 2023 financial results and provide an update on its business and pipeline.

Keros Therapeutics, Inc. today provided a business update and reported financial results for the quarter ended September 30, 2023.

Apnimed, Inc. announced the company will participate in the following investor conferences in November 2023:

Biora Therapeutics, Inc today announced it will report financial results and provide a corporate update for the third quarter ended September 30, 2023.

Mesa Laboratories, Inc., a global leader in the design and manufacturing of life science tools and critical quality control solutions, announced results for its second fiscal quarter ended September 30, 2023.

Akari Therapeutics, Plc today announced that Chief Scientific Officer Miles Nunn will present a poster titled Development of PASylated ® -Nomacopan for Treatment of Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (dAMD) at the 4th Annual Dry AMD Therapeutic Development conference.